Trademark: MAC 2343924
Word
MAC
Device Descrption:
DIAMOND IS PART OF ATOMIC-ORBIT
ID
2343924
Trademark Type
Figurative
Status
Published: Under examination
Deferred
Deferred
Application Date
23 December 2022
Owner(s)
Service
Collison & Co
Goods and Services:
Class 42:
Advisory services relating to scientific research; contract research services in the clinical trial sector; development (research and -) of products in the clinical trial sector; laboratory research services relating to pharmaceuticals; management of scientific research projects; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research; provision of research services in the clinical trial sector; research (scientific-); research and development for others with regard to new products in the clinical trial sector; research to develop new products in the clinical trial sector; research relating to biotechnology; research relating to medicine; research relating to medicines; research relating to pharmaceuticals; scientific research into the development of new products in the clinical trial sector.
Advisory services relating to scientific research; contract research services in the clinical trial sector; development (research and -) of products in the clinical trial sector; laboratory research services relating to pharmaceuticals; management of scientific research projects; medical research; pharmaceutical research services; preparation of reports relating to scientific research; provision of information relating to scientific research; provision of research services in the clinical trial sector; research (scientific-); research and development for others with regard to new products in the clinical trial sector; research to develop new products in the clinical trial sector; research relating to biotechnology; research relating to medicine; research relating to medicines; research relating to pharmaceuticals; scientific research into the development of new products in the clinical trial sector.